SCHEMBL25148409

SCHEMBL25148409

Cc1ccc2c(n1)CCN(c1nnc(C#N)cc1C)C2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.39
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 7/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 3/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.34
TSHR P16473 2/20 0.34
KHK P50053 1/20 0.34
HRH4 Q9H3N8 1/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.31
USP2 O75604 1/20 0.31
CLK1 P49759 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31659844 0.79 CYP11B2 (0.36) PDE10A
SCHEMBL25148081 0.79 CYP11B2 (0.36) PDE10A
SCHEMBL31659721 0.79 GRIN2D (0.32) PDE10AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL25148366 0.79 GRIN2D (0.32) PDE10AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL25148195 0.77 GRIN2D (0.31) PDE10A
SCHEMBL30332146 0.77 GRIN2D (0.31) PDE10A
SCHEMBL31143455 0.75 PDE10A (0.35) PDE10AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL31659478 0.75 GRIN2D (0.30)
SCHEMBL25147741 0.74 P2RX3 (0.36) PDE10A
SCHEMBL25153188 0.74 KDM4E (0.35) KDM4ERECQLHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS VANDERBILT UNIVERSITY 2025-07-17 US disclosed
WO-2023064585-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS VANDERBILT UNIVERSITY (US) 2023-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230155-A1 7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS CHRM5, CHRM4, CHRM1 PDE10A 1498/4885ALDH1A1 1671/4885KDM4E 1122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.